메뉴 건너뛰기




Volumn 17, Issue 11, 2002, Pages 2011-2013

Mycophenolate mofetil in the treatment of resistant idiopathic nephrotic syndrome

Author keywords

Focal segmental glomerulosclerosis; Minimal change nephropathy; Mycophenolate mofetil; Nephrotic syndrome

Indexed keywords

AZATHIOPRINE; CHLORAMBUCIL; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; LEVAMISOLE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; SERUM ALBUMIN; STEROID; TACROLIMUS; DRUG DERIVATIVE; GLUCOCORTICOID; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID;

EID: 0036843138     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/17.11.2011     Document Type: Article
Times cited : (76)

References (9)
  • 1
    • 0028034878 scopus 로고
    • Treatment of childhood steroid-resistant idiopathic nephrosis with a combination of cyclosporine and prednisolone
    • Niaudet P. Treatment of childhood steroid-resistant idiopathic nephrosis with a combination of cyclosporine and prednisolone. J Pediat 1994; 125: 981-986
    • (1994) J. Pediat , vol.125 , pp. 981-986
    • Niaudet, P.1
  • 2
    • 0027786826 scopus 로고
    • Immunosuppressive and other effects of mycophenolic acid and an ester prodrug, mycophenolate mofetil
    • Allison A, Eugui E. Immunosuppressive and other effects of mycophenolic acid and an ester prodrug, mycophenolate mofetil. Immunol Rev 1993; 136: 5-28
    • (1993) Immunol. Rev , vol.136 , pp. 5-28
    • Allison, A.1    Eugui, E.2
  • 3
    • 0031024728 scopus 로고    scopus 로고
    • Mycophenolate mofetil in renal allograft recipients: A pooled efficacy analysis of three randomized, double-blind, clinical studies in prevention of rejection
    • [published erratum appears in Transplantation 1997; 63: 618]
    • Halloran P, Mathew T, Tomlanovich S, Groth C, Hooftman L, Barker C. Mycophenolate mofetil in renal allograft recipients: a pooled efficacy analysis of three randomized, double-blind, clinical studies in prevention of rejection. Transplantation 1997; 63: 39-47 [published erratum appears in Transplantation 1997; 63: 618]
    • (1997) Transplantation , vol.63 , pp. 39-47
    • Halloran, P.1    Mathew, T.2    Tomlanovich, S.3    Groth, C.4    Hooftman, L.5    Barker, C.6
  • 5
    • 0034045586 scopus 로고    scopus 로고
    • Mycophenylate mofetil and its mechanisms of action
    • Allison A, Eugui E. Mycophenylate mofetil and its mechanisms of action. Immunopharmacol 2000; 47: 85-118
    • (2000) Immunopharmacol , vol.47 , pp. 85-118
    • Allison, A.1    Eugui, E.2
  • 6
    • 0033405795 scopus 로고    scopus 로고
    • Non-transplant uses of mycophenolate mofetil
    • Jayne D. Non-transplant uses of mycophenolate mofetil. Curr Opinion Nephrol Hypertens 1999; 8: 563-567
    • (1999) Curr. Opinion Nephrol. Hypertens , vol.8 , pp. 563-567
    • Jayne, D.1
  • 7
    • 0035051925 scopus 로고    scopus 로고
    • Treatment of systemic lupus erythematosus with mycophenylate mofetil
    • Adu D, Cross J, Jayne D. Treatment of systemic lupus erythematosus with mycophenylate mofetil. Lupus 2001; 10: 203-208
    • (2001) Lupus , vol.10 , pp. 203-208
    • Adu, D.1    Cross, J.2    Jayne, D.3
  • 8
    • 17344373954 scopus 로고    scopus 로고
    • Successful mycophenolate mofetil treatment of glomerular disease
    • Briggs W, Choi M, Scheel P. Successful mycophenolate mofetil treatment of glomerular disease. Am J Kidney Dis 1998; 31: 213-217
    • (1998) Am. J. Kidney Dis , vol.31 , pp. 213-217
    • Briggs, W.1    Choi, M.2    Scheel, P.3
  • 9
    • 0032066723 scopus 로고    scopus 로고
    • Follow-up on mycophenolate treatment of glomerular disease
    • Briggs W, Choi M, Scheel P. Follow-up on mycophenolate treatment of glomerular disease. Am J Kidney, Dis 1998; 32: 898-899
    • (1998) Am. J. Kidney Dis , vol.32 , pp. 898-899
    • Briggs, W.1    Choi, M.2    Scheel, P.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.